Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
International Journal of Molecular Sciences|August 7, 2021
The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic TargetTakaomi Kessoku, Takashi Kobayashi, Kosuke Tanaka, et al.Journal of Gastroenterology and Hepatology|May 2, 2022
Comparison of clinical characteristics, eating behaviors, and clinical symptoms following fat intake in functional dyspepsia with functional dyspepsia with pancreatic enzyme abnormalities between Singapore and JapanSeiji Futagami, Takaomi Kessoku, Yuki Kasai, et al.Frontiers in Endocrinology|November 15, 2021
Endotoxins and Non-Alcoholic Fatty Liver DiseaseTakaomi Kessoku, Takashi Kobayashi, Kento Imajo, et al.Cancers|May 14, 2022
Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled TrialAnna Ozaki, Takaomi Kessoku, Kosuke Tanaka, et al.Contemporary Clinical Trials Communications|July 11, 2022
Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipationAtsushi Yamamoto, Takaomi Kessoku, Kosuke Tanaka, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.Journal of Gastroenterology and Hepatology|June 6, 2023
Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populationsSeiji Futagami, Takaomi Kessoku, Yuki Kasai, et al.Diagnostics (Basel, Switzerland)|August 10, 2024
A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care SettingAtsushi Yamamoto, Takaomi Kessoku, Tomoki Ogata, et al.Journal of Gastroenterology and Hepatology|March 12, 2021
Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver diseaseMichihiro Iwaki, Takaomi Kessoku, Anna Ozaki, et al.BMJ Open|May 31, 2022
Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipationKosuke Tanaka, Takaomi Kessoku, Atsushi Yamamoto, et al.Pageof 5